HYPERURICEMIA AS A PREDICTOR OF CHRONIC HEART FAILURE
Aspects of comorbidity in patients with chronic heart failure are discussed. A focus on hyperuricemia, its effect on the course and prognosis in patients with heart failure, as well as the possibility of its medical correction are maintained.
Saved in:
| Main Authors: | M. V. Ledyakhova, S. N. Nasonova, S. N. Tereshchenko |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2015-09-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/134 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Allopurinol in the complex therapy of acute decompensation of heart failure
by: Laura H. Sarieva, et al.
Published: (2025-01-01) -
Possibilities of hyperuricemia correction in acute decompensation of heart failure
by: Laura H. Sarieva, et al.
Published: (2025-01-01) -
Hyperuricemia, gout and comorbidity
by: N. A. Shostak, et al.
Published: (2023-01-01) -
Effect of allopurinol on renal function in chronic kidney disease patients with asymptomatic hyperuricemia
by: 王垚, et al.
Published: (2017-01-01) -
The current treatment strategy for gouty arthritis
by: M. S. Petrova, et al.
Published: (2018-09-01)